Science 37

Science 37 develops a virtual clinical trial management platform that provides eSource and patient engagement solutions for the healthcare sector.

Business Model:

Revenue: $87M

Employees: 501-1,000

Detailed Science 37 Information

Geographic Data

Science 37 headquarters map

Address: 600 Corporate Pointe

City: Culver City

State: CA

Zip: 90230

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$200M

Raised Total:

$237M

Metrics

384,613Website Global Rank

140,328Website Monthly Traffic

Twitter Followers

Description

Science 37 develops a virtual clinical trial management platform that provides eSource and patient engagement solutions for the healthcare sector.

Contact Phone:
+19843773737

Contact Email:

Science 37 went public on 10/7/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/7/2021

IPO Valuation:
$1B

Ticker Symbol:
SNCE

Amount Raised:
$235M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
10/2021 Post-IPO Equity $0 Lux Capital
RTW Investments LLC
Mubadala Capital Ventures
Pura Vida Investments
Casdin Capital
BlackRock
LifeSci Venture Partners
Redmile Group
PPD
Samsara BioCapital
dRx Capital
Perceptive Advisors
RS Investments
Surveyor Capital
Lux Capital
RTW Investments LLC
Mubadala Capital Ventures
Pura Vida Investments
Casdin Capital
BlackRock
LifeSci Venture Partners
Redmile Group
PPD
Samsara BioCapital
dRx Capital
Perceptive Advisors
RS Investments
Surveyor Capital
4/2017 Series C $29M Glynn Capital Management
GV
Amgen Ventures
Lux Capital
Redmile Group
dRx Capital
10/2021 IPO SPAC -
6/2018 Series D $130M SoftBank Corp
Glynn Capital
Google Ventures
Amgen Ventures
Lux Capital
Redmile Group
dRx Capital
Sanofi Ventures.
1/2019 Series D $0 PPD
Redmile Group
Lux Capital
GV
Glynn Capital Management
dRx Capital
PPD
Redmile Group
Lux Capital
GV
Glynn Capital Management
dRx Capital
8/2020 Venture Round $0 Amgen
Lux Capital
PPD
Redmile Group
Amgen
Sanofi Ventures
Novartis
Mubadala Capital Ventures
LifeSci Venture Partners
GV
Glynn Capital Management
Amgen
Lux Capital
PPD
Redmile Group
Amgen
Sanofi Ventures
Novartis
Mubadala Capital Ventures
LifeSci Venture Partners
GV
Glynn Capital Management
4/2017 Series C 7 $35M Glynn Capital Management
Sanofi Ventures
Redmile Group
Lux Capital
GV
dRx Capital
Amgen Ventures
Glynn Capital Management
10/2016 Series B 5 $31M Redmile Group
Sanofi Ventures
Lux Capital
dRx Capital
Arthur Iinuma
Redmile Group
10/2015 Series A 3 $6.5M dRx Capital
Lux Capital
Arthur Iinuma
dRx Capital
Lux Capital
10/2021 IPO SPAC -

8/2020 Venture Round 10 $40M Lux Capital
Redmile Group
PPD, Inc
Novartis
Sanofi Ventures
Google Ventures
Glynn Capital
LifeSci Ventures
Mubadala Ventures
Lux Capital
PPD
Redmile Group
10/2021 Post-IPO Equity 14 $200M Lux Capital
RTW Investments LLC
Mubadala Capital Ventures
Pura Vida Investments
Casdin Capital
BlackRock
LifeSci Venture Partners
Redmile Group
PPD
Samsara BioCapital
Lux Capital
RTW Investments LLC
Mubadala Capital Ventures
Pura Vida Investments
Casdin Capital
BlackRock
LifeSci Venture Partners
Redmile Group
PPD
Samsara BioCapital
1/2019 Series D 6 $35M PPD
PPD
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research